We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCOM icon
501
CALL
Trip.com Group
TCOM
$29.1B
$10K ﹤0.01%
100,000
-100,000
-50% -$2.52M
VRTX icon
502
PUT
Vertex Pharmaceuticals
VRTX
$134B
$10K ﹤0.01%
15,000
GMFIW
503
DELISTED
Aetherium Acquisition Corp Warrant
GMFIW
$10K ﹤0.01%
+73,000
New +$11.2K
TGVCW
504
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$10K ﹤0.01%
+50,000
New +$14K
SHAP.WS
505
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$10K ﹤0.01%
+50,000
New +$11.8K
FXCOW
506
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
$10K ﹤0.01%
+59,400
New +$12.1K
ORIAW
507
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$10K ﹤0.01%
+26,647
New +$13.7K
PTOCW
508
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$10K ﹤0.01%
50,000
+6,234
+14% +$2.16K
BENER
509
DELISTED
Benessere Capital Acquisition Corp. Right
BENER
$10K ﹤0.01%
44,731
-91,106
-67% -$28.9K
ACII.WS
510
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$10K ﹤0.01%
+31,147
New +$13.8K
KSS icon
511
CALL
Kohl's
KSS
$2.1B
$9K ﹤0.01%
+16,200
New +$915K
UHGWW
512
DELISTED
United Homes Group Warrant
UHGWW
$9K ﹤0.01%
25,000
-144,765
-85% -$67.8K
PRLHW
513
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$9K ﹤0.01%
+34,017
New +$9.27K
ZPTAW
514
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
$9K ﹤0.01%
+44,241
New +$9.01K
ACQRW
515
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$9K ﹤0.01%
20,000
-18,320
-48% -$9.65K
FACA.WS
516
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$9K ﹤0.01%
+12,500
New +$10.2K
PICC.WS
517
DELISTED
Pivotal Investment Corporation III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
PICC.WS
$9K ﹤0.01%
+20,000
New +$9.59K
ETACW
518
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$9K ﹤0.01%
50,700
-11,975
-19% -$3.55K
NOVVR
519
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$9K ﹤0.01%
50,000
-90,299
-64% -$21.9K
XBI icon
520
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$8K ﹤0.01%
+29,900
New +$2.76M
ABPWW
521
DELISTED
Abpro Holdings Warrant
ABPWW
$8K ﹤0.01%
+39,874
New +$7.17K
BWAQW
522
DELISTED
Blue World Acquisition Corporation Warrant
BWAQW
$8K ﹤0.01%
+78,478
New +$9.62K
ITAQW
523
DELISTED
Industrial Tech Acquisitions II, Inc. Warrants
ITAQW
$8K ﹤0.01%
+30,900
New +$7.02K
WRAC.WS
524
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$8K ﹤0.01%
30,000
-70,799
-70% -$22.5K
EVOJW
525
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
$8K ﹤0.01%
47,491
-4,508
-9% -$1.81K

Similar funds

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.